CRIS Current Research Information System

ZOLI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.408
AS - Asia 12.548
EU - Europa 11.506
SA - Sud America 756
AF - Africa 749
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 8
Totale 41.008
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.245
VN - Vietnam 4.174
SG - Singapore 3.237
IT - Italia 3.089
CN - Cina 2.658
GB - Regno Unito 2.190
DE - Germania 1.453
SE - Svezia 1.180
HK - Hong Kong 810
IN - India 644
FR - Francia 642
BR - Brasile 529
RU - Federazione Russa 527
NL - Olanda 467
UA - Ucraina 394
IE - Irlanda 392
CH - Svizzera 286
FI - Finlandia 214
ZA - Sudafrica 212
TG - Togo 211
JP - Giappone 203
EE - Estonia 175
KR - Corea 144
BG - Bulgaria 141
CI - Costa d'Avorio 133
JO - Giordania 106
CA - Canada 89
AR - Argentina 85
PH - Filippine 81
SC - Seychelles 67
AT - Austria 65
TH - Thailandia 65
BE - Belgio 56
ID - Indonesia 52
ES - Italia 51
BD - Bangladesh 50
PL - Polonia 50
MX - Messico 42
IQ - Iraq 41
TR - Turchia 40
EC - Ecuador 35
SA - Arabia Saudita 31
CL - Cile 29
UZ - Uzbekistan 29
CD - Congo 27
IR - Iran 27
PK - Pakistan 27
TW - Taiwan 27
AU - Australia 26
CO - Colombia 26
GR - Grecia 24
NG - Nigeria 24
MY - Malesia 22
HR - Croazia 21
PE - Perù 17
MA - Marocco 15
AE - Emirati Arabi Uniti 14
LB - Libano 13
RO - Romania 13
EG - Egitto 12
LT - Lituania 12
PY - Paraguay 12
CZ - Repubblica Ceca 11
IL - Israele 11
VE - Venezuela 11
KE - Kenya 10
TN - Tunisia 10
ET - Etiopia 9
DK - Danimarca 8
HU - Ungheria 7
NP - Nepal 7
NZ - Nuova Zelanda 7
DZ - Algeria 6
JM - Giamaica 6
RS - Serbia 6
UY - Uruguay 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
CR - Costa Rica 5
MK - Macedonia 5
OM - Oman 5
XK - ???statistics.table.value.countryCode.XK??? 5
KZ - Kazakistan 4
NO - Norvegia 4
PT - Portogallo 4
SN - Senegal 4
AM - Armenia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
KH - Cambogia 3
LU - Lussemburgo 3
LV - Lettonia 3
AG - Antigua e Barbuda 2
CY - Cipro 2
DM - Dominica 2
EU - Europa 2
GH - Ghana 2
HN - Honduras 2
KW - Kuwait 2
Totale 40.971
Salva come PNG Salva come JPEG
Città #
Singapore 2.186
Southend 1.880
Fairfield 1.729
Ashburn 1.635
Chandler 1.386
Ho Chi Minh City 813
Woodbridge 766
Hong Kong 750
Dong Ket 742
Seattle 716
Santa Clara 709
Hanoi 689
Wilmington 664
Houston 645
San Jose 611
Cambridge 600
Princeton 487
Ann Arbor 452
Dublin 390
Bologna 382
Beijing 366
Boardman 310
Frankfurt am Main 286
Bern 261
Hefei 256
Lauterbourg 242
Lomé 211
Nanjing 207
Jacksonville 205
Westminster 199
Los Angeles 198
Milan 195
Padova 187
Tokyo 181
Florence 176
Rome 172
Helsinki 168
Da Nang 153
Berlin 147
Sofia 139
Abidjan 133
New York 114
Saint Petersburg 110
Dallas 109
Amman 106
Buffalo 104
Haiphong 104
Council Bluffs 103
Bremen 101
Jinan 99
Turin 99
Munich 95
Seoul 95
San Diego 84
Shenyang 84
Redondo Beach 82
Nanchang 79
Changsha 78
Brescia 77
Redmond 76
Cesena 71
São Paulo 70
Guangzhou 63
Hebei 61
Brussels 55
Des Moines 55
Shanghai 55
Tianjin 52
Naples 51
Amsterdam 50
Falls Church 50
Medford 49
Hangzhou 48
Jiaxing 45
Orem 45
Chicago 44
Bengaluru 43
Dearborn 43
London 43
Biên Hòa 41
Pune 41
Hải Dương 38
Mülheim 38
Redwood City 37
Phoenix 35
Paris 33
Can Tho 32
Thái Nguyên 32
Ningbo 31
Toronto 31
Zhengzhou 31
Falkenstein 30
Warsaw 30
Yubileyny 30
Haikou 29
Ninh Bình 29
Turku 29
Olalla 27
Bangkok 26
Lubumbashi 26
Totale 26.092
Salva come PNG Salva come JPEG
Nome #
DIABETE MELLITO TIPO 2 ED EVENTI ARITMICI NEL PAZIENTE ANZIANO. OSSERVAZIONI MEDIANTE MONITORAGGIO ECG HOLTER 1.568
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 478
Prognostic value of non-alcoholic fatty liver disease in the elderly patients 403
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 342
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 280
Prognostic role of nutritional status in elderly patients hospitalized for COVID-19: a monocentric study 276
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 260
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 260
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 255
Accuracy of Lung Ultrasound in Patients with Acute Dyspnea: The Influence of Age, Multimorbidity and Cognitive and Motor Impairment 255
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 253
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 251
T-31 Nonalcoholic fatty liver disease and aging. Clinical course and cardiovascular risk 250
Chronic endurance exercise training prevents aging-related cognitive decline in healthy older adults: a randomized controlled trial. 249
Adipocyte-fatty acid binding protein and non-alcoholic fatty liver disease in the elderly 249
Association between accelerated multimorbidity and age-related cognitive decline in older Baltimore longitudinal study of aging participants without dementia. 246
“Delirium Day”: a nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 243
Effects of weight loss and risk factor treatment in subjects with elevated serum C3, an inflammatory predictor of myocardial infarction. 241
Clinical Features Associated with Delirium Motor Subtypes in Older Inpatients: Results of a Multicenter Study 241
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 241
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 239
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 239
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 239
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 238
Risk of Exclusion From Stroke Rehabilitation in the Oldest Old 237
Aging and the burden of multimorbidity: Associations with inflammatory and anabolic hormonal biomarkers 235
Pattern of macrovascular invasion in hepatocellular carcinoma 233
MARK-AGE population: From the human model to new insights 231
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 230
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 220
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database 219
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 216
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 216
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 215
Adverse effects of proton pump inhibitors. 214
Postprandial splanchnic haemodynamic changes in patients with liver cirrhosis and patent paraumbilical vein 213
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma 213
Psychological status and depression in patients with liver cirrhosis 210
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 209
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 208
T-30 Cognitive profiles in patients with cirrhosis and long-term liver transplant recipients 208
The Senile Lung as a Possible Source of Pitfalls on Chest Ultrasonography and Computed Tomography 207
Predictors of cognitive impairment assessed by Mini Mental State Examination in community-dwelling older adults: relevance of the step test 206
Age dependency of regional impedance indices regardless of clinical stage in patients with cirrhosis of the liver 205
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 205
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 203
Aging and Multimorbidity: New Tasks, Priorities, and Frontiers for Integrated Gerontological and Clinical Research 202
Inverse Association Between Neck Pain and All-Cause Mortality in Community-Dwelling Older Adults 202
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 201
Age-specific rate of undiagnosed diabetes and prediabetes in acute stroke 201
The changing scenario of hepatocellular carcinoma in Italy: an update 200
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20 year multicentre experience. 199
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 198
T-33 Liver steatosis in old subjects could be a predictor of possible cardiac abnormalities 198
Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia. 197
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 197
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 194
Metabolic disorders across hepatocellular carcinoma in Italy 193
N-terminal pro B-type natriuretic peptide (NT-proBNP): a possible surrogate of biological age in the elderly people 193
The association of proBNPage with manifestations of age-related cardiovascular, physical, and psychological impairment in community-dwelling older adults 191
A Case of Acute Liver Failure during Ritonavir-Boosted Paritaprevir, Ombitasvir and Dasabuvir Therapy in a Patient with HCV Genotype 1b Cirrhosis 191
Clinical Role of Lung Ultrasound for the Diagnosis and Prognosis of Coronavirus Disease Pneumonia in Elderly Patients: A Pivotal Study 189
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 189
Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report. 188
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 188
Insulin Resistance Is Associated With Reduced Mitochondrial Oxidative Capacity Measured by 31P-Magnetic Resonance Spectroscopy in Participants Without Diabetes From the Baltimore Longitudinal Study of Aging 187
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 184
Alfa-fetoprotein in hepatocellular carcinoma (HCC): diagnostic and prognostic role, clinical and biological predictors. Analysis of 1099 patients. 184
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders. 183
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 183
Peliosis hepatis as an early histological finding in idiopathic portal hypertension: a case report. 183
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 182
A comparative assessment of C3 complement, C-reactive protein, leukocyte count and erythrocyte sedimentation rate as inflammatory markers of insulin resistance in an elderly population 180
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 179
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 179
Serum C3 is a stronger inflammatory marker of insulin resistance than C reactive protein, leukocyte count, and erythrocyte sedimentation rate. Comparison study in an elderly population. 178
Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension 178
Combination of the clock drawing test with the physical phenotype of frailty for the prediction of mortality and other adverse outcomes in older community dwellers without dementia 178
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 178
Determinants of mean platelet volume (MPV) in an elderly population: Relevance of body fat, blood glucose and ischaemic electrocardiographic changes. 176
Mortality after admission to stroke unit for intracerebral hemorrhage: Effect of age 80 and older and multimorbidity 176
Bioavailable testosterone linearly declines over a wide age spectrum in men and women from the Baltimore longitudinal study of aging. 176
Early body composition, but not body mass, is associated with future accelerated decline in muscle quality 176
Post COVID-19 irritable bowel syndrome 175
Serum dehydroepiandrosterone sulfate and adverse health outcomes in older men and women. 175
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 175
Plasma amino acid concentrations in patients with Amnestic Mild Cognitive Impairment or Alzheimer Disease 174
Physical Activity and Other Determinants of Survival in the Oldest Adults 174
"Physical Fitness and life extension." Lo studio Pianoro 173
Age as a possible Independent Prognostic Factor for Overall Survival and Recurrence-Free Survival after Transarterial Chemoembolization in Hepatocellular Carcinoma Patients 173
Loss of weight in obese older adults: A biomarker of impending expansion of multimorbidity? 172
Liver hemangioma and vascular liver diseases in patients with systemic lupus erythematosus. 172
Hepatic decompensation is the major driver of death In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. 169
Torsade de pointes” during amiodarone infusion in cirrhotic woman with the prolonged QT interval. 168
Metabolic syndrome and all-cause mortality in older men and women. 167
Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD? 167
Circulating ceramides are inversely associated with cardiorespiratory fitness in participants aged 54-96 years from the Baltiore Longitudinal Study of Aging. 167
Albumin-induced hematocrit-lowering and B-type natriuretic peptide increase 166
EQ-5D as a predictor of mortality and hospitalization in elderly people. 166
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 166
Totale 22.399
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.821
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.695 0 0 0 0 0 0 0 0 0 208 150 1.337
2021/20224.701 385 141 279 289 421 258 140 287 216 289 1.233 763
2022/20235.725 572 916 289 736 282 405 198 311 881 149 541 445
2023/20241.682 104 241 100 157 179 343 79 83 93 107 93 103
2024/20256.002 265 863 501 444 1.058 335 399 200 132 477 257 1.071
2025/202612.006 998 908 1.013 889 1.438 840 1.898 395 2.738 889 0 0
Totale 41.667